The Relative Strength (RS) Rating for Chemours moved up into a higher percentile Tuesday, as it got a lift from 70 to 77.
When To Sell Stocks To Lock In Profits And Minimize Losses
This proprietary rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves. See if Chemours can continue to show renewed price strength and hit that benchmark.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to form a chart pattern and break out.
In terms of top and bottom line numbers, Chemours has posted two quarters of rising earnings growth. Sales gains have also increased during the same period.
The company holds the No. 11 rank among its peers in the Chemicals-Specialty industry group. Perimeter Solutions, NewMarket and Ingevity are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
